IL1B and schistosomiasis: Quantification of inflammatory mediators in liver fragments from a chronic model of schistosomiasis showed a significant decrease in TNF-α, IL-1β (P < 0.01) and IL-6 (P < 0.001) levels (Fig. 3A–C) after cell therapy.